CATALOGO DEI PRODOTTI DELLA RICERCA

RIBICHINI, Flavio Luciano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.512
EU - Europa 7.008
AS - Asia 3.904
AF - Africa 82
SA - Sud America 35
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 19.558
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.468
CN - Cina 2.331
GB - Regno Unito 2.201
SG - Singapore 1.285
RU - Federazione Russa 858
FR - Francia 720
IE - Irlanda 696
SE - Svezia 606
IT - Italia 556
FI - Finlandia 515
DE - Germania 484
UA - Ucraina 191
TG - Togo 67
KR - Corea 65
BE - Belgio 46
JP - Giappone 44
NL - Olanda 35
CA - Canada 30
VN - Vietnam 28
TR - Turchia 25
HK - Hong Kong 22
IR - Iran 22
BR - Brasile 21
RO - Romania 15
AU - Australia 13
ID - Indonesia 13
IN - India 11
CH - Svizzera 10
IL - Israele 9
LT - Lituania 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
PA - Panama 6
PE - Perù 6
PL - Polonia 6
PT - Portogallo 6
BG - Bulgaria 5
EG - Egitto 5
MY - Malesia 5
NO - Norvegia 5
ES - Italia 4
HU - Ungheria 4
LU - Lussemburgo 4
LV - Lettonia 4
MA - Marocco 4
MX - Messico 4
PH - Filippine 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BY - Bielorussia 3
CO - Colombia 3
DK - Danimarca 3
EE - Estonia 3
JO - Giordania 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TJ - Tagikistan 3
CL - Cile 2
DO - Repubblica Dominicana 2
IS - Islanda 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TW - Taiwan 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
PY - Paraguay 1
SC - Seychelles 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 19.558
Salva come PNG Salva come JPEG
Città #
Southend 2.004
Jacksonville 1.474
Chandler 1.369
Singapore 1.080
Woodbridge 905
Dublin 685
Ann Arbor 533
Ashburn 532
Beijing 409
Houston 403
New York 342
Lawrence 276
Princeton 276
Wilmington 252
Jinan 209
Helsinki 183
Nanjing 159
Shenyang 153
Verona 140
Hebei 130
Sindelfingen 82
Tianjin 80
Seattle 78
Nanchang 69
Munich 67
Changsha 66
Lomé 66
Milan 62
Zhengzhou 62
Haikou 61
Moscow 56
Seoul 56
Washington 54
Taizhou 51
Guangzhou 49
Ningbo 48
Boardman 47
Brussels 46
Hangzhou 46
Norwalk 46
Taiyuan 46
Santa Clara 45
Fuzhou 41
Jiaxing 40
Redwood City 37
Dallas 33
Redmond 32
Fairfield 31
Kent 29
Lanzhou 26
Falls Church 25
Los Angeles 23
Dong Ket 22
Hong Kong 19
Lancaster 19
San Francisco 19
Tokyo 19
Bologna 17
Tappahannock 17
Toronto 17
Amsterdam 16
Frankfurt am Main 16
Lappeenranta 16
Cambridge 15
Detroit 15
London 15
Rome 13
Falkenstein 12
Jakarta 12
Shanghai 12
Romola 11
Dongguan 10
Edinburgh 10
Cedar Knolls 9
Dearborn 9
Chicago 8
Esslingen am Neckar 8
Zanjan 8
Baku 7
Bishkek 7
Clearwater 7
San Diego 7
Atlanta 6
Auburn Hills 6
Bari 6
Lima 6
Ottawa 6
Saint Louis 6
Turin 6
Venice 6
Warsaw 6
Cairo 5
Leawood 5
Melbourne 5
New Delhi 5
Olomouc 5
Oslo 5
Ravenna 5
Sofia 5
Zurich 5
Totale 13.605
Salva come PNG Salva come JPEG
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 494
[The use of activated clotting time (ACT) to optimize heparinization during coronary angioplasty. The nursing personnel of the Hemodynamics Laboratory]. 126
First successful management of aortic valve insufficiency associated with HeartMate II left ventricular assist device support by transfemoral CoreValve implantation: the Columbus's egg? 118
In-stent restenosis. 114
Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale 113
Drug-coated balloon: Long-term outcome from a real world three-center experience 105
[Analysis of right electrocardiographic leads in 195 normal subjects]. 101
Hemodynamic predictors of long term survival in end stage cystic fibrosis 101
Short communication: staff dose reduction during coronary angiography using low framing speed. 99
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 98
[Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct]. 98
Effects of Aortic Valve Replacement on Left Ventricular Diastolic Function in Patients With Aortic Valve Stenosis 96
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 95
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 94
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. 93
Plasma Lipoprotein (a) is not a predictor for restenosis after elective high-pressure coronary stenting. 92
Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients 91
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 90
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). 90
A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease: The EXECUTIVE Trial (EXecutive RCT: Evaluating XIENCE V in a Multi Vessel Disease). 90
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 90
On the current epidemic outburst of meta-analytic rage in interventional cardiology. 89
On-line quantitative coronary analysis in clinical practice: one step closer to reality? 89
Elective coronary angioplasty with and without surgical standby: clinical and angiographic criteria for the selection of patients. 89
Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization 89
Risk stratification in acute coronary syndromes. 89
Early aggressive treatment of unstable angina without on-site cardiac surgical facilities: a prospective study of acute and long-term outcome. 88
[Elective coronary angioplasty in total absence of heart surgery]. 88
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 88
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 88
Veno-Venous Extracorporeal Membrane Oxygenation as a Bridge to and Support for Pulmonary Thromboendarterectomy in Misdiagnosed Chronic Thromboembolic Pulmonary Hypertension 88
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 87
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 87
A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale. 87
Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. 87
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. 87
Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. 86
Ambulation three hours after elective cardiac catheterisation through the femoral artery. 86
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 86
Correlation between Angiographic and Physiologic Evaluation of Coronary Artery Narrowings in Patients With Aortic Valve Stenosis 86
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 85
Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. 84
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 84
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 84
Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity 84
[Emergency angioplasty in high-risk acute infarct]. 83
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 83
Optimizing the role of transthoracic echocardiography to improve the cardiovascular risk stratification: the dream of subclinical coronary artery disease detection 83
[Radiologic practice and radioprotection in Italian hemodynamic laboratories]. 82
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 82
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 82
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 81
[Heart catheterization via the femoral artery with a 4 French and mobilization at 2 hours]. 81
[Quality assurance and cost control in invasive and interventional cardiology]. 81
Functional mitral regurgitation: are we treating the real target? 81
Angiotensin-converting enzyme tissue activity in the diffuse in-stent restenotic plaque. 80
Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques. 80
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 80
Angiographic follow-up after coronary implantation of the Multilink stent: a prospective observation. 80
[Primary angioplasty in acute inferior myocardial infarct with anterior ST-segment depression: the long-term follow-up]. 80
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 80
Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial. 80
Plasma Activity and Insertion/Deletion Plymorphism of Angiotensin-Converting Enzyme: A Major Risk Factor and a Marker of Risk for Coronary Stent Restenosis. 78
Angiotensin antagonism in coronary artery disease: results after coronary revascularisation. 78
Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study 78
Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial 78
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 78
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. 77
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants 77
Percutaneous transcatheter balloon valvuloplasty for severe tricuspid valve stenosis in Ebstein's anomaly. 77
Unsuspected infrahepatic interruption of inferior vena cava associated with floppy mitral valve, mitral valve prolapse, and severe mitral regurgitation. 77
[Diagnostic hemodynamics in day-hospital care]. 77
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 77
Accuracy of Micro-Computed Tomography in Post-mortem Evaluation of Fetal Congenital Heart Disease. Comparison Between Post-mortem Micro-CT and Conventional Autopsy 77
Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty. 76
Prevalence of patients with severely reduced aortic valve area and low gradient despite a preserved ejection fraction. Results from a cath-lab data base. 76
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives 76
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 76
Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis 75
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries 75
Left internal mammary artery graft stenosis. Atherosclerosis, spasm or kinking? 75
Dyspnea following thoracostomy closure after right pneumonectomy: An uncommon echocardiographic diagnosis and therapeutic approach 75
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 75
Acute myocardial infarction: reperfusion treatment. 74
The diagnosis of coronary artery disease in hypertensive patients with chest pain and complete left bundle branch block: utility of adenosine Tc-99m tetrofosmin SPECT. 74
Coronary stenting after unsuccessful emergency angioplasty in acute myocardial infarction: results in a series of consecutive patients. 74
[Invasive cardiological diagnosis in an ambulatory regimen of transported inpatients]. 74
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 74
The Common Combination of Aortic Stenosis with Mitral Regurgitation: Diagnostic Insight and Therapeutic Implications in the Modern Era of Advanced Echocardiography and Percutaneous Intervention 74
Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis 73
Concomitant myocardial infarction in identical twins with similar coronary lesions. 73
Transfemoral Edwards-Novaflex valve implantation in a patient with aorto-iliac endoprosthesis and severely tortuous bilateral external iliac arteries-"Railing track". 73
First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm 73
Early functional and structural changes of the left atrium in a patient with trastuzumab: related cardiotoxicity 73
A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages. 72
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. 72
Predicting cardiac events with Tl201 dipyridamole myocardial scintigraphy in renal transplant recipients. 72
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease 72
Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy 72
Is TAVI superior to surgery in high-risk patients? Insight into the concept of individual risk assessment 71
Totale 8.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.427
article - articoli 86.427
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.854
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.314 0 0 0 0 0 344 136 149 84 213 108 280
2020/20212.347 264 409 125 345 300 267 28 130 127 62 245 45
2021/20221.722 171 350 15 103 80 47 25 107 67 71 185 501
2022/20234.309 319 454 450 643 351 1.040 91 284 478 22 108 69
2023/20242.862 87 197 277 305 313 595 134 214 23 170 375 172
2024/20252.811 370 414 237 1.182 378 230 0 0 0 0 0 0
Totale 19.862